AI, Pharma Services and Tariffs: The Healthcare Outlook from HPE New York
In mid-October, McDermott Will & Schulte’s Healthcare Private Equity New York conference brought healthcare leaders together to analyze the key challenges and trends shaping the industry in 2025. For one busy day, attendees heard from a series of panels that guided them through the complexities of private equity in healthcare and highlighted the most compelling investment sectors. It should be noted that media at the conference were bound by the Chatham House Rule, so we will refer to panelists anonymously unless we have received direct permission to use their names. “The boom days are back,” one panelist declared, echoing the enthusiasm at the conference around the... Read More »
Inside the 2025 Clinical Trials M&A Market
The clinical trials market, part of our newly formed Life Sciences R&D sector, has seen a shift in M&A deal volume over the last few years. The post-pandemic dealmaking frenzy has cooled, with acquirers now making more strategic and deliberate moves over the large-scale expansion of previous years. According to data captured in the LevinPro HC database, deal volume was modest before the post-pandemic surge, with 12 deals in 2019, 14 in 2020 and 18 in 2021. Volume escalated more than 66% in 2022 when 30 deals were reported. It hit a high in 2023 when 43 acquisitions were announced. However, M&A activity fell 37% in 2024 with 27 deals. If activity continues at its current pace,... Read More »
Private Equity Interest Drops in First Half of 2025
In the first half of 2025, private equity firms and their sponsored companies (“PE Buyers,” collectively) announced 326 transactions in the healthcare M&A market, or approximately 32% of all the 1,036 announced healthcare deals, according to data captured in the LevinPro HC platform. The deal volume in Q2:25 (148 deals) represents a nearly 17% decrease in M&A volume from Q1:25 (178 deals). Activity in Q2:25 is also 24% lower than the 194 PE-backed transactions reported in the second quarter of 2024. For the first two quarters of the year, disclosed spending reached more than $32.8 billion across 17 transactions. The first quarter saw more than $29.9 billion in disclosed spending... Read More »
Top States for Physician Medical Group M&A
As the Physician Medical Group (PMG) market evolves, geography remains a key factor influencing deal activity across the United States. While much of the focus in healthcare M&A tends to center around active specialties or prolific buyers, geography also offers insights into a deeper understanding of the market. There are several questions that come up when thinking about the importance of geography in terms of the M&A market. What states have seen the most activity? Do the most active states differ based on specialty? And how do regulations impact activity in each state? According to data captured in the LevinPro HC database, since the start of 2024, there have been... Read More »
Key Trends at the McGuireWoods 21st Annual Healthcare Private Equity and Finance Conference
The 21st Annual McGuireWoods Healthcare Private Equity and Finance Conference was held May 13–15, in Chicago, drawing healthcare leaders from across the industry to explore the shifting dynamics of healthcare M&A. The conference offered a front-row seat to the trends shaping 2025. Attendees shared cautious optimism, noting opportunities in a market shaped by regulatory and economic challenges. The conference spotlighted a market at a crossroads. Conference participants highlighted regulatory challenges, including state transaction notices and reimbursement pressure, as hurdles slowing deal activity. They also noted liquidity constraints in the middle market as a... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
